The effects of zinc supplementation on serum adiponectin level and insulin resistance in patients with type II diabetes mellitus

Endocrinology & Metabolism Research Center0 个研究点目标入组 60 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•Age between 30 to 50 years, presence of type 2 diabetes at least for one year, willingness to participate in the study and sign the informed consent, BMI=25-30, HbA1C=8.5, Blood pressure =135/85 mmHg. Exclusion criteria: severe kidney, heart, liver, GI, pulmonary and infectious diseases, thyroid dysfunction, active cancer, previous myocardial infarction, recent surgery, Insulin therapy, changing in dose of medications such as oral anti-diabetic, anti-lipidemic and anti-hypertensive drugs 3 month before and during the study, consumption of vitamin-mineral supplements 6 month before and during the study, consumption of non-steroidal anti inflammatory drugs, glucocorticoids, hormonal drugs, antidepressants, psychotropic medications, antibiotics, dioretics, three months prior to study, Following weight-reducing diet 3 months before and during the study, smoking, pregnancy, breast feeding, postmenopausal women.

发起方

Endocrinology & Metabolism Research Center